NERM
AGN

New England Research & Management’s Allergan Inc AGN Stock Holding History

New England Research & Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,975
Closed -$219K – 170
2013
Q4 		$219K Buy
+1,975
New +$189K 0.21% 142

Other funds holding AGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

New England Research & Management's AGN Position: Q1 2014 in Review

New England Research & Management sold out of Allergan Inc (AGN) in Q1 2014, closing a stake of 1,975 shares — an estimated $219K sold.

New England Research & Management first reported a position in AGN in Q4 2013 and held it in 1 quarter. The position peaked at $219K in Q4 2013. 733 funds tracked by Wall St. Rank hold AGN as of Q1 2014.

  • New England Research & Management reported no remaining Allergan Inc position as of Q1 2014 after selling out during the quarter.
  • New England Research & Management sold 1,975 Allergan Inc shares in Q1 2014, an estimated $219K.
  • New England Research & Management first reported a position in Allergan Inc in Q4 2013 and held it in 1 quarter.
  • New England Research & Management's Allergan Inc position peaked at $219K in Q4 2013.
  • 733 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2014.

Based on New England Research & Management's 13F filing for Q1 2014, filed 16 Apr 2014.